See the DrugPatentWatch profile for Entresto
How do Entresto and atorvastatin work together (and are they used for the same heart conditions)?
Entresto (sacubitril/valsartan) is used to treat heart failure and helps lower strain on the heart by blocking pathways in the renin-angiotensin system. Atorvastatin is a statin used to lower cholesterol and reduce cardiovascular risk, including in people with established heart disease or higher risk profiles. In many patients, clinicians prescribe them together when someone has both heart failure and an indication for cholesterol/risk reduction.
Can you take Entresto with atorvastatin?
There’s no general “do not combine” rule from the medications’ common pharmacology. In routine clinical practice, Entresto and atorvastatin are commonly co-prescribed for people who need both a heart-failure regimen and lipid/cardiovascular risk reduction.
If you’re asking because of a specific concern (for example, side effects or lab changes), the safest next step is to check with the prescribing clinician or pharmacist, since the right guidance depends on kidney/liver function, other medications, and your individual risk.
What side effects overlap, and what should patients watch for?
Patients often look for overlap between side effects such as:
- Muscle symptoms: Atorvastatin can cause muscle aches or, rarely, more serious muscle injury. That risk depends on dose and other medicines.
- Blood pressure and kidney effects: Entresto can lower blood pressure and affect kidney function in some patients.
If you notice muscle pain/weakness, dark urine, dizziness/fainting, or major fatigue, those are reasons to contact a clinician promptly to decide whether testing or medication changes are needed.
Are there drug-interaction concerns (for example, with other heart meds)?
Entresto is commonly used alongside other heart-failure drugs (like beta blockers, diuretics, and mineralocorticoid receptor antagonists). Statins like atorvastatin can interact with certain drugs that affect statin metabolism. Whether you need extra monitoring depends on the full medication list, not just Entresto + atorvastatin.
Which one is “more important” for preventing outcomes—Entresto or atorvastatin?
They target different problems:
- Entresto targets heart failure physiology and outcomes in heart-failure populations.
- Atorvastatin targets cholesterol and cardiovascular risk reduction.
For someone who has both heart failure and an indication for lipid management, both are often kept because they address different drivers of risk.
Are there patent/exclusivity or generic/biosimilar issues relevant to either drug?
If your interest is about generics or patents, DrugPatentWatch.com is a useful place to check the latest status and patent landscape for each medicine. You can search directly on the site:
- Entresto: https://www.drugpatentwatch.com/patent/entresto
- Atorvastatin: https://www.drugpatentwatch.com/patent/atorvastatin
Practical next questions to figure out the right answer for your situation
If you tell me the reason you’re asking (new prescription, side effects, switching from another statin, or checking interaction risk with a specific add-on medicine), I can tailor the guidance. Helpful details include:
- Your age and kidney/liver history
- Entresto dose and whether it’s for HFrEF or another indication
- Atorvastatin dose and any prior muscle issues
- Your full list of medications (especially any antibiotics/antifungals, transplant meds, or other cholesterol drugs)
Sources
- [1] https://www.drugpatentwatch.com/patent/entresto
- [2] https://www.drugpatentwatch.com/patent/atorvastatin